Medpace Holdings, Inc. MEDP EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Medpace Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medpace Holdings, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medpace Holdings, Inc.'s EBITDA margin?
- Medpace Holdings, Inc. (MEDP) reported EBITDA margin of 22.1% in Q1 2026.
- How has Medpace Holdings, Inc.'s EBITDA margin changed year-over-year?
- Medpace Holdings, Inc.'s EBITDA margin decreased by 2.0% year-over-year, from 22.5% to 22.1%.
- What is the long-term trend for Medpace Holdings, Inc.'s EBITDA margin?
- Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s EBITDA margin has grown at a 2.0% compound annual growth rate (CAGR), from 20.1% to 22.3%.
- What does EBITDA margin mean?
- Operating cash profitability per sales dollar, before interest, taxes, and non-cash charges.
- How do you interpret EBITDA margin?
- Useful for comparing operating profitability across firms with different depreciation policies and leverage. High EBITDA margin alongside heavy capex can still mean weak free cash flow — pair it with FCF margin.
- How does EBITDA margin compare across companies?
- Widely used to compare capital-intensive businesses on a like-for-like basis. Less meaningful for banks and insurers.